Citi Pharma Receives CCP Approval for Acquisition of Pakheim International Pharma
Citi Pharma Limited has received authorization from the Competition Commission of Pakistan (CCP)...
Read More
Category: Citi Pharma Ltd. (CPHL)
Citi Pharma Limited Reports Higher Sales but Lower Profit for FY2026
Citi Pharma Limited Records 6.5% Sales Growth in FY2026 as Profit Declines Citi Pharma Limited has...
Read More
Citi Pharma Approves Demerger Scheme, Plans Transfer of Key Lahore Properties to SPV
KARACHI: Citi Pharma Limited has announced that its Board of Directors has approved and...
Read MoreCiti Pharma Limited Announces Strategic Financial Collaboration with JS Global Capital
Citi Pharma Limited has taken another significant step toward long-term growth and financial excellence through a strategic collaboration with JS Global Capital Limited. The company recently welcomed CEO Khalil Usmani and his...
Read MoreCiti Pharma Accelerates Growth with Strategic Acquisition of Pakheim International Pharmaceuticals
Citi Pharma Limited (PSX: CPHL) has announced a significant milestone in its growth journey with the proposed acquisition of 100% shareholding in Pakheim International Pharmaceuticals (Private) Limited. The transaction, approved...
Read More
Citi Pharma Posts 30% Rise in Nine-Month Profit as Sales and Operating Performance Improve
Lahore: Citi Pharma Limited reported a solid financial performance for the nine months ended March...
Read More